Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Can-Fite Biopharma Ltd (CANF) Normalized Income after Taxes data is not available for the most recently reported fiscal quarter, ending 2024-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Normalized Income after Taxes |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$5.83M |
|
$0.03M |
|
$0.09M |
|
$5.92M |
|
$1.99M |
|
-- |
|
$1.46M |
|
$3.44M |
|
$2.48M |
|
$2.48M |
|
$2.48M |
|
5.57M |
|
| Cash Flow Statement Financials | |
$-4.04M |
|
$4.50M |
|
-- |
|
$4.28M |
|
$4.72M |
|
$0.44M |
|
$0.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|